FDA: Don’t Rely On Device Labeling To ‘Design Out’ Product Risks
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers shouldn’t make the mistake of using product labeling to mitigate device risks, according to a recent FDA draft guidance. Instead, firms should “design out” those risks to ensure that they only make quality products, an agency official says.